| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/27/1990 | CA1266234A1 Method of binding microflora |
| 02/22/1990 | WO1990001335A1 Treatment of gastro-intestinal disorders |
| 02/22/1990 | WO1990001326A1 Preparation and use of a physiologically active polypeptide for treating aids |
| 02/22/1990 | WO1990001271A1 Process for producing antioxidant, biologically active extracts and oily, greasy compositions rich in vitamins and their use as an active ingredient of industrial, therapeutic and cosmetic preparations, as well as an active ingredient added to nutrients and to fodder |
| 02/22/1990 | WO1990001266A1 Transplantig cultured epithelial cells with a desired phenotypic trait |
| 02/21/1990 | CN1039723A Powder quick dissolving donkey-hide gelatin |
| 02/20/1990 | US4902716 Anti-viral chamigrene derivatives |
| 02/20/1990 | US4902509 Process for the isolation of chicken egg cystatin, antiviral agents containing it and its use as viral protease inhibitor |
| 02/20/1990 | US4902508 Tissue graft composition |
| 02/20/1990 | US4902295 Transplantable artificial tissue |
| 02/20/1990 | US4902288 Grafting immunologically activated anticancer cells carried by biocompatible matrix support |
| 02/15/1990 | DE3926658A1 Fettsaeurezusammensetzung Fettsaeurezusammensetzung |
| 02/15/1990 | DE3827490A1 Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie Fitting and use of a physiologically active polypeptide for AIDS-therapy |
| 02/14/1990 | EP0354592A1 A novel human physiologically active polypeptide |
| 02/14/1990 | EP0354492A2 Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
| 02/14/1990 | EP0354354A2 Process for concentrating blood coagulation factors II, VII, IX en X |
| 02/13/1990 | US4900720 Plasmapheresis |
| 02/13/1990 | US4900553 Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
| 02/08/1990 | WO1990000898A1 A surface and biologically active preparation |
| 02/07/1990 | EP0353581A2 Pharmaceutical compositions comprising selected lactobacillus strains |
| 02/07/1990 | EP0353381A2 Antibiotic LL-E19085 Alpha |
| 02/07/1990 | EP0177564B1 Method and apparatus for filtration |
| 02/07/1990 | CN1039352A Tissue graft composition and method |
| 02/06/1990 | CA1265462A1 Antibiotic a42125 and process for its production |
| 02/06/1990 | CA1265446A1 Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component |
| 02/06/1990 | CA1265445A1 Composition for use in treating inflammation |
| 02/06/1990 | CA1265444A1 Effect of human tumor necrosis factor and human interferon on human cancer cells and methods |
| 02/05/1990 | EP0302058A4 Method of processing animal cartilage and product produced. |
| 01/31/1990 | EP0352299A1 Rubradirin derivatives for treatment of hiv infection |
| 01/30/1990 | US4897265 Method for treating disorders of the vascular and pulmonary systems |
| 01/30/1990 | US4897252 Production of hydrogen peroxide |
| 01/30/1990 | CA1265059A1 Process to produce a stable coal tar-containing shampoo |
| 01/30/1990 | CA1265051A1 Pasteurized, isoagglutinin-free factor viii preparation and a process for its production |
| 01/30/1990 | CA1265050A1 Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices |
| 01/25/1990 | WO1990000395A1 Tissue graft composition and method |
| 01/25/1990 | WO1990000394A1 Natriuretic hormone |
| 01/23/1990 | US4895932 Method for determining cardiodilatin and fragments thereof and antibodies useful in determination of cardiodilatin and its fragments |
| 01/23/1990 | US4895833 Lactation increase |
| 01/23/1990 | US4895566 Coating medical devices with cationic antibiotics |
| 01/17/1990 | EP0351173A2 Substance having anti-retrovirus activity |
| 01/17/1990 | EP0351045A2 Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 01/17/1990 | EP0350973A1 Means and product for the diagnosis and therapy of tumours and for the treatment of weaknesses of the cellular and humoral immune system |
| 01/17/1990 | CN1038764A Production technology of disease-resistant silk-raising agent |
| 01/11/1990 | WO1990000063A1 Identification of human t-lymphocyte epitopes in pathogens for vaccine development |
| 01/11/1990 | WO1990000059A1 Procedure and container for the preparation and storage of platelet concentrates |
| 01/11/1990 | EP0281621A4 Glucose free media for storing blood platelets. |
| 01/10/1990 | EP0349545A1 New cardiodilatin fragment, process for preparing same and use thereof. |
| 01/10/1990 | EP0210332B1 Process for the purification of plasminogen activators |
| 01/10/1990 | CN1038649A Extraction and purification of an anticoagulant principle from the south american leech haementeria ghilanii |
| 01/10/1990 | CN1038585A Clear away heart-fire liquid and process for preparing same |
| 01/09/1990 | US4892731 Clostridium butyricum |
| 01/09/1990 | US4892538 In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| 01/09/1990 | US4892537 Bag for separation and isolation of blood components |
| 01/08/1990 | EP0315627A4 A method to treat blood. |
| 01/08/1990 | EP0289584A4 Wound healing and bone regeneration. |
| 01/08/1990 | EP0287652A4 Serum-free medium for the proliferation of lymphokine-activated killer cells. |
| 01/08/1990 | EP0273039A4 Extracellular matrix induction method to produce pancreatic islet tissue. |
| 01/03/1990 | EP0349049A2 Immunosuppressant compound |
| 01/03/1990 | EP0349048A2 Osteogenic growth factors derived from regenerating bone marrow |
| 01/03/1990 | EP0348781A2 Procyanidol oligomeric fractions, the processes for the preparation thereof and pharmaceutical compositions containing them |
| 01/03/1990 | EP0348413A1 Method for the generation of antigen-specific t cell lines and therapeutic use thereof |
| 01/03/1990 | EP0211835B1 Pharmaceutical compositions of microbially produced interleukin-2 |
| 01/03/1990 | CN1038406A Method for processing medicinal mercury powder (zuotai) |
| 01/02/1990 | US4891319 Protection of proteins and the like |
| 01/02/1990 | US4891221 Whole blood antiviral process and composition |
| 12/28/1989 | WO1989012644A1 Endotoxin binding protein and uses thereof |
| 12/28/1989 | WO1989012459A1 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 12/28/1989 | WO1989012390A1 Biocompatible, substance-specific reagents for treating physiological fluids |
| 12/27/1989 | EP0348353A2 The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases |
| 12/27/1989 | EP0348290A2 Activated killer monocytes : tumoricidal activity and method of monitoring same |
| 12/27/1989 | EP0348208A2 Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| 12/27/1989 | EP0348042A1 Method of modifying the lipid structure of cell membranes |
| 12/27/1989 | EP0347932A2 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
| 12/27/1989 | EP0347899A2 Pharmaceutical compositions on egg shell basis and their preparation and use |
| 12/27/1989 | EP0347448A1 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases |
| 12/27/1989 | CN1038306A Recombinant retroviruses |
| 12/27/1989 | CA1264032A1 Biologic and method of preparing same |
| 12/27/1989 | CA1264031A1 Biocompatible container and method for in situ production of functional platelets lacking immunogenicity |
| 12/20/1989 | EP0346894A2 Extraction and purification of an anticoagulant substance from the south american leech, haementeria ghilianii |
| 12/20/1989 | EP0346831A2 Antibiotics and process for producing them |
| 12/20/1989 | EP0346472A1 Process for preparing liposomes |
| 12/19/1989 | US4888324 Extraction with first and second solvent system |
| 12/19/1989 | US4888291 Human epithelium originating from cell cultures |
| 12/19/1989 | US4888280 Nucleotide sequence; dna transfer vector |
| 12/19/1989 | US4888172 Pharmaceutical for treating tumors and methods for making it |
| 12/19/1989 | US4888171 Anhydrous binder containing cells surrounding core; storage stability |
| 12/19/1989 | CA1263954A1 Ganglioside derivatives |
| 12/19/1989 | CA1263937A1 Polypeptide factors from colostrum |
| 12/14/1989 | WO1989012065A1 Chromatographic separation of plasma proteins |
| 12/14/1989 | WO1989011859A1 Pharmaceutical compositions and use thereof in treating inflammation |
| 12/14/1989 | WO1989011858A1 Treatment of immunodeficiency |
| 12/13/1989 | EP0345943A1 Device for plasma modification composition and remodeling |
| 12/13/1989 | EP0345850A1 Composition having anti-endotoxic activity |
| 12/13/1989 | EP0345614A2 Amblyommine as an agent for use in antithrombotic therapy |
| 12/13/1989 | EP0179127B1 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
| 12/12/1989 | US4886779 Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols |
| 12/12/1989 | US4886758 Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
| 12/07/1989 | DE3818675A1 Process for the production of a raw material based on whey |
| 12/06/1989 | EP0345100A1 Preparation of PAF receptors and method of quantity determination of PAF |
| 12/05/1989 | US4885170 Antibiotic A80509 |